Global CBD Nutraceuticals Market Insights Forecasts to 2033

• The Global CBD Nutraceuticals Market Size was Valued at USD 9.29 Billion in 2023
• The Market Size is Growing at a CAGR of 12.57% from 2023 to 2033
• The Worldwide CBD Nutraceuticals Market Size is Expected to Reach USD 30.35 Billion by 2033
• Asia Pacific is expected to grow the fastest during the forecast period.

The Global CBD Nutraceuticals Market Size is anticipated to exceed USD 30.35 billion by 2033, growing at a CAGR of 12.57% from 2023 to 2033. The growing demand for CBD nutraceuticals is being driven by several consumer trends, chief among them being the move toward natural and plant-based wellness products.  

Market Overview

A pharmaceutical substitute that makes physiological claims is called a nutraceutical. A nutraceutical product is a food or fortified food item that offers medicinal advantages by helping to treat or prevent disease in addition to supplementing the diet. Cannabidiol (CBD), a naturally occurring substance in plants, is a member of the cannabinoid family. Capsules, gummies, and even beverages containing CBD are often preferred by patients and persons with long-term health conditions like chronic pain, sleeplessness, and others. The FDA has approved Epidiolex, a cannabis-derived medication; and three synthetic cannabis-related drug products from which Marinol and Syndros medications contain synthetic THC (dronabinol) while Cesamet medication contains nabilone, a synthetic analog of THC. The rising incidence of chronic illnesses, rising consumer knowledge of the health advantages of cannabidiol (CBD), and scientific advancements in the nutraceuticals sector are some of the primary factors driving the growth in CBD nutraceuticals market. Increased knowledge of health and well-being prevention strategies has fueled the expansion of several sectors, including the CBD nutraceuticals market.    

Report Coverage

This research report categorizes the CBD nutraceuticals market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the CBD nutraceuticals market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the CBD nutraceuticals market.

Driving Factors

Growing customer desire for plant-based supplements and increased knowledge of cannabidiol's medicinal benefits, especially its restorative qualities, are major factors driving the market growth.  Significant shifts in consumer preferences and a propensity for plant- and herbal-based consumer health products are also driving the CBD nutraceuticals market. Increased consumer demand for plant-based supplements, growing knowledge of cannabidiol's therapeutic qualities and other medical benefits, the legalization of hemp-derived CBD products in several nations, and rising living standards are some of the main factors driving growth in the CBD nutraceuticals market.   

Restraining Factors

Regulation ambiguity, legal limits, quality control issues, a lack of scientific proof, rivalry from well-established businesses, high prices, possible adverse effects, and the persistent societal stigma associated with cannabis-related goods are all factors restricting the CBD nutraceuticals market.     

Market Segmentation

The CBD nutraceuticals market share is classified into product and distribution channel.  

• The CBD tinctures segment is estimated to hold the largest market revenue share through the projected period.  

Based on the product, the CBD nutraceuticals market is classified into CBD tinctures, capsules & softgels, CBD gummies, and others. Among these, the CBD tinctures segment is estimated to hold the largest market revenue share through the projected period. The product's potential to reduce certain cancer symptoms, ease of availability, and effective solutions for health issues such as help with substance use disorders, depression, and chronic pain all are driving the growth of the CBD tinctures market

• The retail stores segment is anticipated to hold the largest market share through the forecast period.

Based on the distribution channel, the CBD nutraceuticals market is divided into retail stores, online, and pharmacies. Among these, the retail stores segment is anticipated to hold the largest market share through the forecast period. The retail store segment has grown as a result of factors like accessibility, the availability of several options, and the choice of major corporations to achieve more brand visibility.

Regional Segment Analysis of the CBD Nutraceuticals Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the CBD nutraceuticals market over the predicted timeframe.

North America is anticipated to hold the largest share of the CBD nutraceuticals market over the predicted timeframe. The main factors propelling market in North America are growing consumer awareness, the expanding use of CBD in a variety of applications, and favourable regulatory environments in nations like the US and Canada. The development of this industry in recent years has also been aided by the existence of a strong healthcare infrastructure and well-equipped research and development facilities focused on scientific breakthroughs in the application of CBD as well as innovations about its use in foods, cosmetics, and medications.

Asia Pacific is expected to grow at the fastest CAGR growth of the CBD nutraceuticals market during the forecast period.  The market is largely driven by the Asia Pacific region's potential for legalizing CBD, the growing acceptance of CBD for medical purposes, the startling rise in new cases of chronic and noncommunicable diseases in the region, and the cultural significance of cannabis in nations like India.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the CBD nutraceuticals market along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• dsm-firmenich
• CV Sciences, Inc
• Green Roads
• Elixinol
• Irwin Naturals
• Medical Marijuana, Inc.
• Argent BioPharma Ltd
• Diamond CBD.
• Medterra CBD
• Charlotte's Web, Inc.
• Foria Wellness
• Isodiol International Inc
• Bluebird Botanicals
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In June 2024, CBtru, a sophisticatedly constructed cannabidiol (CBD) therapeutic product intermediate intended for oral solid delivery formats, was launched by dsm-firmenich.    

• In May 2024, the leading consumer wellness company CV Sciences, Inc., which specializes in hemp extracts and other natural ingredients and products with scientific support, announced that it has completed the acquisition of Elevated Softgels, LLC ("Elevated Softgels"), a top producer of tinctures and encapsulated soft gels for the supplement and nutrition sector.   

Market Segment

• This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the CBD nutraceuticals market based on the below-mentioned segments: 

Global CBD Nutraceuticals Market, By Product

• CBD Tinctures
• Capsules & Softgels
• CBD Gummies
• Others

Global CBD Nutraceuticals Market, By Distribution Channel

• Retail Stores
• Online
• Pharmacies

Global CBD Nutraceuticals Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa